DESIDERI, ISACCO
 Distribuzione geografica
Continente #
NA - Nord America 10.543
EU - Europa 6.782
AS - Asia 6.562
SA - Sud America 814
AF - Africa 126
OC - Oceania 113
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 24.942
Nazione #
US - Stati Uniti d'America 10.415
RU - Federazione Russa 3.253
SG - Singapore 1.986
CN - Cina 1.914
HK - Hong Kong 998
IT - Italia 957
KR - Corea 740
BR - Brasile 657
IE - Irlanda 624
PL - Polonia 501
SE - Svezia 372
DE - Germania 287
VN - Vietnam 265
FR - Francia 217
IN - India 212
FI - Finlandia 167
GB - Regno Unito 153
JO - Giordania 148
AU - Australia 110
ID - Indonesia 91
CA - Canada 68
AR - Argentina 60
NL - Olanda 47
ES - Italia 45
CH - Svizzera 37
MX - Messico 35
EC - Ecuador 30
JP - Giappone 28
BD - Bangladesh 26
ZA - Sudafrica 26
IQ - Iraq 25
CI - Costa d'Avorio 24
BE - Belgio 22
TR - Turchia 22
VE - Venezuela 20
CZ - Repubblica Ceca 19
CO - Colombia 16
UA - Ucraina 16
PK - Pakistan 15
EG - Egitto 14
MA - Marocco 14
LT - Lituania 13
AT - Austria 11
BJ - Benin 11
TN - Tunisia 10
PY - Paraguay 9
KE - Kenya 8
BG - Bulgaria 7
CL - Cile 7
DO - Repubblica Dominicana 7
IL - Israele 7
KG - Kirghizistan 7
PH - Filippine 7
UY - Uruguay 7
UZ - Uzbekistan 7
KZ - Kazakistan 6
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
BY - Bielorussia 5
GR - Grecia 5
PE - Perù 5
SA - Arabia Saudita 5
SC - Seychelles 5
SK - Slovacchia (Repubblica Slovacca) 5
AZ - Azerbaigian 4
DK - Danimarca 4
DZ - Algeria 4
LA - Repubblica Popolare Democratica del Laos 4
MM - Myanmar 4
PS - Palestinian Territory 4
BO - Bolivia 3
HU - Ungheria 3
IR - Iran 3
KH - Cambogia 3
LB - Libano 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
BH - Bahrain 2
CR - Costa Rica 2
EE - Estonia 2
GE - Georgia 2
HN - Honduras 2
KW - Kuwait 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
PT - Portogallo 2
RO - Romania 2
SN - Senegal 2
TM - Turkmenistan 2
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
ET - Etiopia 1
GD - Grenada 1
Totale 24.924
Città #
Santa Clara 2.660
Singapore 1.426
Ashburn 1.135
Fairfield 886
Hong Kong 864
Seoul 740
Hefei 733
Dublin 622
Chandler 574
Warsaw 489
Seattle 410
Woodbridge 401
Cambridge 361
Houston 340
Beijing 303
Wilmington 298
Moscow 217
Los Angeles 194
Munich 189
Florence 174
Ann Arbor 170
Buffalo 161
Lawrence 159
Altamura 147
Paris 125
Dearborn 118
New York 116
Princeton 115
Kent 114
Melbourne 104
Ho Chi Minh City 101
Shanghai 91
Mumbai 89
Boston 81
Milan 68
Dallas 64
Jakarta 60
São Paulo 59
San Diego 58
Turku 58
The Dalles 54
Clifton 53
London 53
Medford 52
Helsinki 51
Rome 51
Bengaluru 50
Hanoi 50
West Jordan 41
Frankfurt am Main 38
Boardman 34
Lappeenranta 33
Bern 30
Brooklyn 28
Pune 26
Redondo Beach 25
Stockholm 25
Abidjan 24
Toronto 23
Brussels 22
Tokyo 22
Belo Horizonte 21
Chicago 21
Dong Ket 21
San Francisco 19
Falls Church 18
Barcelona 17
Montreal 17
Rio de Janeiro 17
Atlanta 16
Guangzhou 16
Buenos Aires 15
Hillsboro 15
Yubileyny 15
Johannesburg 14
Phoenix 14
Porto Alegre 14
Baghdad 13
Brasília 13
Norwalk 13
Poplar 13
Chennai 12
Mexico City 12
Nanjing 12
Naples 12
Quito 12
Redwood City 12
Biên Hòa 11
Bologna 11
Campinas 11
Cotonou 11
Vienna 11
Brno 10
Denver 10
Orem 10
Tianjin 10
Shenzhen 9
Wroclaw 9
Amman 8
Caracas 8
Totale 16.382
Nome #
Hypofractionation in prostate cancer: radiobiological basis and clinical appliance. 292
A multiparametric method to assess the MIM deformable image registration algorithm 251
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 246
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis 242
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial 225
Accuracy of Orthopantomography for Apical Periodontitis without Endodontic Treatment 220
Is Panoramic Radiography an Accurate Imaging Technique for the Detection of Endodontically Treated Asymptomatic Apical Periodontitis? 219
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 207
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 207
Stereotactic vacuum-assisted breast biopsy: Comparison between 11- and 8-gauge needles 203
A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients 202
Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment 199
Clinical outcomes and secondary glaucoma after gamma-knife radiosurgery and Ruthenium-106 brachytherapy for uveal melanoma: a single institution experience 198
ADAM phantom to test 4D medical imaging and dose delivery devices 198
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 197
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 196
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 195
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 194
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab 192
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 190
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 190
Influence of age and subtype in outcome of operable liposarcoma 188
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures 183
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 181
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 181
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors? 179
Combined use of a transmission detector and an epid-based in vivo dose monitoring system in external beam whole breast irradiation: A study with an anthropomorphic female phantom 175
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 175
Radiotherapy in the age of cancer immunology: Current concepts and future developments 174
Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature 174
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 174
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 173
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 173
AIRO Breast Cancer Group Best Clinical Practice 2022 Update 172
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 172
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 171
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial 171
CT assessment of tumor heterogeneity and the potential for the prediction of human papillomavirus status in oropharyngeal squamous cell carcinoma 170
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 167
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 166
Delta radiomics: a systematic review 166
TomoTherapy treatments of multiple brain lesions: an in-phantom accuracy evaluation 166
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies 164
Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series 164
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 164
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 164
Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study. 164
Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer 164
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 162
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 162
Regorafenib in glioblastoma recurrence: A case report 161
Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 159
A dosimetric comparison between CyberKnife and tomotherapy treatment plans for single brain metastasis 159
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 159
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience 157
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 157
Methodological approach to create an atlas using a commercial auto-contouring software 157
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients 156
Artificial Intelligence in radiotherapy: state of the art and future directions 156
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis 156
Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study 156
Endocrine-related adverse events in a large series of cancer patients treated with anti-PD1 therapy 156
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 153
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 153
Ribociclib plus letrozole and concomitant palliative radiotherapy for metastatic breast cancer 151
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 150
Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions 150
PV-0512: Accelerated partial breast irradiation for Luminal-A breast cancer: analysis from a phase 3 trial 149
Biomarkers in wound drainage fluids of head and neck squamous cell carcinoma patients receiving neck dissection: A pilot study 148
A critical review on oligometastatic disease: a radiation oncologist’s perspective 147
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 147
Validation of a secondary dose check tool against Monte Carlo and analytical clinical dose calculation algorithms in VMAT 147
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 147
Is panoramic radiography really a key examination before chemo-radiotherapy treatment for oropharyngeal cancer? 147
Morphological, Functional and Texture Analysis Magnetic Resonance Imaging Features in the Assessment of Radiotherapy-Induced Xerostomia in Oropharyngeal Cancer 146
Analysis of skin dose distribution for the prediction of severe radiation dermatitis in head and neck squamous cell carcinoma patients treated with concurrent chemo-radiotherapy 146
Nutritional Supplement Based on Zinc, Prebiotics, Probiotics and Vitamins to Prevent Radiation-related Gastrointestinal Disorders 146
Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin 144
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 143
Thermal Ablation versus SBRT in liver tumours: pros and cons 143
Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literature 142
Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 Patients treated with a prospective margin-directed policy 142
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO 141
Impact of COVID-19 on workload burden of a complex radiotherapy facility 141
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 140
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 140
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 140
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer 140
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years 139
Hypofractionated Postmastectomy Radiotherapy (HF-PMRT): What did We Learn from COVID-19 Era? 137
Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: single-institution experience and review of published literature 137
Dosimetric Predictors of Acute and Chronic Alopecia in Primary Brain Cancer Patients Treated With Volumetric Modulated Arc Therapy 137
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy 137
Magnetic resonance imaging in naso-oropharyngeal carcinoma: role of texture analysis in the assessment of response to radiochemotherapy, a preliminary study 136
Clinical validation of an automatic atlas-based segmentation tool for male pelvis CT images 136
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 135
Cyclin-Dependent Kinase 4/6 Inhibitors Combined With Radiotherapy for Patients With Metastatic Breast Cancer 135
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) 134
The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma 133
Conventional and Advanced Magnetic Resonance Imaging Assessment of Non-Enhancing Peritumoral Area in Brain Tumor 133
Totale 16.723
Categoria #
all - tutte 81.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.717


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021675 0 0 0 0 0 71 67 70 115 170 126 56
2021/2022824 28 46 65 62 24 49 32 79 39 52 121 227
2022/20232.604 174 499 109 112 190 509 357 183 310 14 84 63
2023/20241.611 70 116 181 83 92 224 63 396 36 143 147 60
2024/20259.207 297 865 516 1.453 2.430 1.100 153 516 466 314 435 662
2025/20266.737 1.268 1.599 1.368 1.138 1.322 42 0 0 0 0 0 0
Totale 25.153